- Home
- RGR vs XERS Comparison
RGR vs XERS Comparison
Compare RGR & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- XERS
- Stock Information
- Founded
- RGR 1949
- XERS 2005
- Country
- RGR United States
- XERS United States
- Employees
- RGR N/A
- XERS N/A
- Industry
- RGR Ordnance And Accessories
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- XERS Health Care
- Exchange
- RGR Nasdaq
- XERS Nasdaq
- Market Cap
- RGR 616.8M
- XERS 628.7M
- IPO Year
- RGR N/A
- XERS 2018
- Fundamental
- Price
- RGR $37.22
- XERS $4.51
- Analyst Decision
- RGR
- XERS Strong Buy
- Analyst Count
- RGR 0
- XERS 6
- Target Price
- RGR N/A
- XERS $6.25
- AVG Volume (30 Days)
- RGR 168.6K
- XERS 2.1M
- Earning Date
- RGR 07-30-2025
- XERS 08-07-2025
- Dividend Yield
- RGR 1.94%
- XERS N/A
- EPS Growth
- RGR N/A
- XERS N/A
- EPS
- RGR 1.83
- XERS N/A
- Revenue
- RGR $534,561,000.00
- XERS $222,551,000.00
- Revenue This Year
- RGR N/A
- XERS $35.03
- Revenue Next Year
- RGR $1.89
- XERS $18.31
- P/E Ratio
- RGR $20.24
- XERS N/A
- Revenue Growth
- RGR 0.65
- XERS 29.88
- 52 Week Low
- RGR $32.74
- XERS $2.03
- 52 Week High
- RGR $46.40
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- RGR 52.42
- XERS 46.97
- Support Level
- RGR $37.28
- XERS $4.30
- Resistance Level
- RGR $37.90
- XERS $4.79
- Average True Range (ATR)
- RGR 0.68
- XERS 0.23
- MACD
- RGR 0.16
- XERS -0.01
- Stochastic Oscillator
- RGR 64.08
- XERS 25.93
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).